Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Founded in 2017, cultivate(MD) is a venture capital fund based in the United States, specializing in the medical device sector. The firm focuses on early-stage investments, with a portfolio that includes four companies and a commitment to addressing critical healthcare challenges.
cultivate(MD) invests in early-stage medical device companies, emphasizing technologies that enhance healthcare outcomes and lower costs. Their investment strategy includes Seed and Accelerator Funds, along with the Opportunity Fund, which builds on prior investments.
Notable portfolio companies include Embody, Inc., a regenerative medicine company acquired in 2023; Imascap, which develops software for shoulder replacement surgery planning and was acquired in 2017; Shoulder Innovations, creator of the InSet™ Total Shoulder Replacement System, with a planned IPO on July 31, 2025; and SPDx, which provides sterile processing support and was acquired in 2025.
Submit through their form at cultivate-md.com.
Yes, cultivate(MD) often leads investment rounds in the companies they back, particularly in the early stages of development.
The firm actively considers follow-on investments to support portfolio companies as they grow and achieve key milestones.
Specific fund size details are not disclosed, but cultivate(MD) focuses on early-stage investments in the medical device sector.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.